In addition, in a diethylnitrosamine (DEN)-induced in situ model of hepatocellular carcinoma (HCC), compared to control mice, mice with macrophage CD146 deficiency had a higher tumor incidence and more surface tumors (Fig. 3C–E). This evidence concerns the gene MCAM and hepatocellular carcinoma.